Polysomnographic characteristics and cardiac function in coronary artery disease patients with nonsleepy obstructive sleep apnoea

Y. Peker (Istanbul, Turkey), B. Balcan (Istanbul, Turkey), H. Glantz (Gothenburg, Sweden), E. Thunström (Gothenburg, Sweden)

Source: International Congress 2018 – Epidemiology, phenotypes and cardiometabolic comorbidities of obstructive sleep apnoea
Disease area: Sleep and breathing disorders

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Peker (Istanbul, Turkey), B. Balcan (Istanbul, Turkey), H. Glantz (Gothenburg, Sweden), E. Thunström (Gothenburg, Sweden). Polysomnographic characteristics and cardiac function in coronary artery disease patients with nonsleepy obstructive sleep apnoea. 4965

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical and polysomnographic determinants of REM predominant obstructive sleep apnoea and response to treatment in a revascularized coronary artery disease cohort
Source: Virtual Congress 2020 – Diagnostic characteristics and consequences of sleep and breathing disorders
Year: 2020

Outcomes in coronary artery disease patients with sleepy obstructive sleep apnoea on CPAP
Source: Eur Respir J, 50 (6) 1700749; 10.1183/13993003.00749-2017
Year: 2017



Cardiovascular outcomes in patients with coronary artery disease and nonsleepy versus sleepy obstructive sleep apnoea phenotypes in the RICCADSA trial
Source: Virtual Congress 2021 – The different faces of sleep disturbances in respiratory diseases and beyond
Year: 2021


Influence of obstructive sleep apnea in coronary artery disease: an 8-years-follow-up
Source: Eur Respir J 2003; 22: Suppl. 45, 22s
Year: 2003

Long-term effects of cardiac rehabilitation on sleep apnea severity in patients with coronary artery disease
Source: International Congress 2017 – CPAP therapy
Year: 2017


Nocturnal cardiac dysrhythmias induced by sleep apnoea in adults with or without hypertension and coronary artery disease
Source: Eur Respir J 2003; 22: Suppl. 45, 183s
Year: 2003

Undiagnosed COPD and overlapping obstructive sleep apnoea in coronary heart disease
Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care
Year: 2017

Prevalence of cardiovascular risk factors and coronary artery disease in patients with obstructive sleep apnea syndrome (OSAS) requiring CPAP treatment
Source: Eur Respir J 2006; 28: Suppl. 50, 814s
Year: 2006

High prevalence of obstructive sleep apnoea in revascularized patients with coronary artery disease – RICCADSA trial
Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea
Year: 2008


Natural course of untreated obstructive sleep apnoea in patients with coronary artery disease in the RICCADSA trial
Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing
Year: 2021



Changes in extracranial arteries in obstructive sleep apnoea
Source: Eur Respir J 2005; 25: 69-74
Year: 2005



Heart rate turbulence: In patients with obstructive sleep apnea without coronary artery diseases
Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain
Year: 2011


Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up
Source: Eur Respir J 2006; 28: 596-602
Year: 2006



Impact of CPAP-therapy on cardiac structure and function in patients with obstructive sleep apnea syndrome and coprevalent arterial hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 817s
Year: 2006

Association between obstructive sleep apnea syndrome and coronary atherosclerostic disease
Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Year: 2007


Systematic coronary risk evaluation among obstructive sleep apnea patients
Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing
Year: 2018


Atherosclerosis of the carotid arteries in patients with COPD and obstructive sleep apnea (OSA).
Source: International Congress 2017 – Central sleep apnoea: consequences and comorbidities of obstructive sleep apnoea
Year: 2017

Obstructive sleep apnoea and coronary artery disease
Source: International Congress 2016 – PG18 Sleep apnoea and comorbidities
Year: 2016



Coronary plaque distribution and endothelial dysfunction in younger obstructive sleep apnea patients
Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism
Year: 2011